[Effectiveness of cardiovascular prevention in primary care]
- PMID: 11784482
- PMCID: PMC7681737
- DOI: 10.1016/s0212-6567(01)70477-5
[Effectiveness of cardiovascular prevention in primary care]
Abstract
Objectives: To evaluate the modification of risk factors and of coronary risk (CR) in adults (14-75 years old) after a period of 1 to 5 years in the PAPPS (special prevention programme).
Design: Multi-centre intervention study with no before-and-after random allocation.
Setting: Primary care.
Participants: Patients included in the PAPPS at 3 health centres, 634 monitored for five years, 890 for four years, 1605 for 3 years and 2829 for 2 years, were evaluated.Interventions. Minimum counselling to give up tobacco and over-consumption of alcohol, and educational and pharmacological measures to reduce cholesterol and blood pressure.
Main measurements: Recording of blood pressure, cholesterol, weight, and tobacco and alcohol consumption. CR was determined in the sub-group of 30-75 years old. These variables were determined at the start and end of the various monitoring periods.
Results: CR was reduced by between 0.2 and 0.3%; systolic blood pressure, by between 0.4 and 0.9 mmHg; diastolic pressure, by between 0.3 and 0.7 mmHg; cholesterol, by between 0.5 and 2.5 mg/dl; percentage of smokers, by between 0.3 and 2.8%; and over-consumption of alcohol, by between 0.2 and 1%.
Conclusions: Scant success of the interventions to reduce CR and risk factors in the population as a whole. The main use of cardiovascular prevention programmes with many factors resides in detecting high-risk patients for subsequent intervention.
Objetivos: Evaluar la modificación de los factores de riesgo y del riesgo coronario en adultos (14–75 años) tras un período de entre 1 y 5 años de ser incluidos en el PAPPS.
Diseño: Estudio multicéntrico de intervención sin asignación aleatoria antesdespués.
Emplazamiento: Atención primaria
Participantes: Se evalúa a los pacientes incluidos en el PAPPS de 3 centros salud, 634 seguidos durante 5 años, 890 durante 4 años, 1.605 durante 3 años y 2.829 durante 2 años.
Intervenciones: Consejo mínimo para abandonar tabaco y consumo excesivo de alcohol, medidas educacionales y farmacológicas para reducir colesterol y presión arterial.
Mediciones principales: Toma de la presión arterial, colesterol, peso, consumo tabaco y alcohol. En el subgrupo 30–75 años determinación del riesgo coronario. Estas variables se determinaron al inicio y al final de los distintos períodos de seguimiento.
Resultados: La reducción del riesgo coronario fue entre el 0,2 y el 0,3%, de la presión arterial sistólica entre 0,4 y 0,9 mmHg, y de la diastólica entre 0,3 y 0,7 mmHg, del colesterol entre 0,5 y 2,5 mg/dl, del porcentaje de fumadores entre el 0,3 y el 2,8% y del consumo excesivo de alcohol entre el 0,2 y el 1%.
Conclusiones: Escasa repercusión de las intervenciones realizadas para reducir el riesgo coronario o los factores de riesgo en la población total. La utilidad principal de los programas de prevención cardiovascular y multifactoriales estribaría en la detección de los pacientes de alto riesgo para, posteriormente, intervenir sobre ellos.
Comment in
-
[The selection of high-risk patients: the objective of reduction of cardiovascular risk].Aten Primaria. 2002 Jun 15;30(1):70; author reply 70. doi: 10.1016/s0212-6567(02)78967-1. Aten Primaria. 2002. PMID: 12106584 Free PMC article. Spanish. No abstract available.
References
-
- Goode G.K., Miller J.P., Heagerty A.M. Hyperlipidaemia, hiper-tension, and coronaruy heart disease. Lancet. 1995;345:362–364. - PubMed
-
- Kottke T.E., Battista R.N., DeFruiee G.H., Brekke M.L. Atributes of successful smoking cessation intervention in medical practice. A meta-analysis of 39 controlled trial. JAMA. 1988;259:2882–2889. - PubMed
-
- Silagy C., Mant D., Fowler G., Lodge M. Meta-analysis of efficacy of nicotine replacement therapies in smoking cessation. Lancet. 1994;308:139–142. - PubMed
-
- Gould A.L., Rossouw J.E., Santanello N.C., Heyse J.F., Furberg C.D. Cholesterol reduction yields clinical benefit. Impact of statin trials. Circulation. 1998;97:946–952. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources